Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial
AYY Lee, PW Kamphuisen, G Meyer, R Bauersachs… - Jama, 2015 - jamanetwork.com
Importance Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial
AYY Lee, PW Kamphuisen, G Meyer… - JAMA-Journal of the …, 2015 - scholarworks.bwise.kr
Importance: Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer.
AYY Lee, PW Kamphuisen, G Meyer… - JAMA: Journal of …, 2015 - search.ebscohost.com
IMPORTANCE Low-molecular-weight heparin is recommended over warfarin for the
treatment of acute venous thromboembolism (VTE) in patients with active cancer largely …
treatment of acute venous thromboembolism (VTE) in patients with active cancer largely …
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial
AYY Lee, PW Kamphuisen, G Meyer… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Importance Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
[PDF][PDF] Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer. A randomized clinical trial
AYY Lee, PW Kamphuisen, G Meyer, R Bauersachs… - JAMA, 2015 - core.ac.uk
Methods The CATCH study was a two-arm parallel design randomized, open-label study
with blinded central adjudication of study outcomes. 900 adult patients with active cancer …
with blinded central adjudication of study outcomes. 900 adult patients with active cancer …
[引用][C] Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial
AYY Lee, PW Kamphuisen, G Meyer, R Bauersachs… - JAMA, 2015 - elibrary.ru
Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial
CATCH Investigators - JAMA, 2015 - mahidol.elsevierpure.com
Importance: Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial
CATCH Investigators - JAMA-Journal of the American …, 2015 - snucm.elsevierpure.com
Importance: Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial
CATCH Investigators - JAMA-Journal of the American …, 2015 - scholar.nycu.edu.tw
Importance: Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial
CATCH Investigators - JAMA-Journal of the American Medical …, 2015 - pure.korea.ac.kr
Importance: Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …